Melflufen well tolerated with encouraging activity in heavily pretreated R/R MM Presented ByDr Enrique Ocio, University Hospital Marqués de Valdecilla, Spain TrialPhase 1/2, ANCHOR (OP-104) ConferenceASH 2020 18 February, 2021 10:22